MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$84,945,901
Interest income
$2,420,160
Net unrealized gain
on...
$1,114,781
Change in fair value of
common stock warrant...
-$493,231
Gain (loss) on
investment in affiliated...
$489,844
Loss from operations
-$86,822,104
Revenue from
collaborative arrangement
$65,343
Other expense, net
-$2,641,813
Total operating
expenses
$86,887,447
Research and development
$54,206,874
General and
administrative
$32,680,573
Back
Back
Income Statement
source: myfinsight.com
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)